Nanjing King-friend Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NANJING KING-FRIEND, and what generic and branded alternatives to NANJING KING-FRIEND drugs are available?
NANJING KING-FRIEND has eight approved drugs.
Drugs and US Patents for Nanjing King-friend
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nanjing King-friend | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 211004-001 | Feb 24, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nanjing King-friend | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 211007-002 | May 28, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nanjing King-friend | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 211007-001 | May 28, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nanjing King-friend | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 211007-003 | May 28, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nanjing King-friend | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 215861-001 | Aug 14, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nanjing King-friend | HEPARIN SODIUM PRESERVATIVE FREE | heparin sodium | INJECTABLE;INJECTION | 212060-001 | Apr 2, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.